Uniplan Investment Counsel’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-72,072
| Closed | -$750K | – | 132 |
|
|
2020
Q3 | $750K | Buy |
72,072
+2,361
| +3% | +$24.6K | 0.05% | 120 |
|
|
2020
Q2 | $916K | Sell |
69,711
-1,864
| -3% | -$24.5K | 0.06% | 116 |
|
|
2020
Q1 | $563K | Buy |
71,575
+10,126
| +16% | +$79.7K | 0.04% | 119 |
|
|
2019
Q4 | $1.27M | Buy |
61,449
+974
| +2% | +$20.2K | 0.08% | 116 |
|
|
2019
Q3 | $828K | Sell |
60,475
-3,973
| -6% | -$54.4K | 0.05% | 115 |
|
|
2019
Q2 | $792K | Sell |
64,448
-15,900
| -20% | -$195K | 0.05% | 123 |
|
|
2019
Q1 | $1M | Sell |
80,348
-12,529
| -13% | -$156K | 0.06% | 117 |
|
|
2018
Q4 | $1.05M | Sell |
92,877
-3,088
| -3% | -$34.9K | 0.07% | 111 |
|
|
2018
Q3 | $1.8M | Sell |
95,965
-13,038
| -12% | -$244K | 0.1% | 106 |
|
|
2018
Q2 | $2.82M | Sell |
109,003
-19,921
| -15% | -$515K | 0.14% | 100 |
|
|
2018
Q1 | $2.89M | Buy |
128,924
+1,820
| +1% | +$40.8K | 0.14% | 111 |
|
|
2017
Q4 | $3.18M | Buy |
127,104
+3,200
| +3% | +$80.1K | 0.13% | 113 |
|
|
2017
Q3 | $3M | Buy |
+123,904
| New | +$3M | 0.13% | 110 |
|